Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy Meeting Abstract


Authors: Till, J. E.; Abdalla, A.; Bhagwat, N.; Black, T. A.; Wang, Z. Y.; Yee, S. S.; Gherardini, P. F.; Kitch, L. J.; Selinsky, C.; Lyman, J. P.; LaVallee, T.; Fisher, G. A.; Rahma, O. E.; Ko, A. H.; Wainberg, Z. A.; Wolff, R. A.; O'Reilly, E. M.; Vonderheide, R. H.; O'Hara, M. H.; Carpenter, E. L.
Abstract Title: Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120602222
DOI: 10.1200/JCO.2021.39.15_suppl.4122
PROVIDER: wos
Notes: Meeting Abstract: 4122 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly